- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06023082
A Single-Group Study to Examine the Efficacy of a Gut Health Supplement to Increase Metabolism, Improve Gut Health, and Support Weight Management
This study will evaluate the efficacy of Colon Broom Premium on gut health, metabolism, weight management, and energy levels. The study will be conducted as a virtual single-group trial in which all 120 participants will use the test product. This study will last 12 weeks, and participants will take the product daily. Participants will complete study-specific questionnaires at Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12. Participants will also provide body weight measurements and body circumference measurements at Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12.
Before & after photographs will be provided at Baseline and Week 12.
The Colon Broom Premium supplement contains psyllium seed husk powder, L-carnitine tartrate, CapsimaxⓇ cayenne fruit extract, chromium (as chromium picolinate), vitamin B6 (as pyridoxine HCl), vitamin B12 (as cyanocobalamin), and Iron.
The study Sponsor and product name will remain anonymous to participants throughout the trial. The Sponsor name or product name will not be included in any participant-facing documentation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female between ages 30-50
- Have a BMI of 25 or more
- Have self-reported issues with gas, bloating, constipation, heartburn/acid reflux, abdominal pain, or digestion at least three times per week
- Be willing to maintain their standard dietary pattern, activity level, and body weight for the duration of the study
- Be generally healthy - do not live with any uncontrolled chronic disease
Exclusion Criteria:
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone who is currently undergoing, or planning to to undergo any gut or weight-related procedures in the next 12 week.
- Anyone with a history of severe allergic reactions including but not limited to psyllium seed husk powder and strawberries
- Anyone taking any prescription medications targeting the gut
- Anyone taking any supplements targeting the gut in the past month
- Use of antibiotics in the past 3 months
- Women who are pregnant, breastfeeding, or attempting to become pregnant
- Anyone unwilling to follow the study protocol
- Anyone following any particular dietary regime, such as a ketogenic diet or intermittent fasting.
- Anyone who has had bariatric surgery in the past 6 months
- Anyone who has chronic constipation
- Anyone who has Irritable Bowel Disease (IBD)
- Anyone diagnosed with severe digestive issues
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Colon Broom Premium supplement
Participants will add 1 scoop (0.23 oz/ 6.47 g) to 12-14 fl oz of water, mix well and drink immediately. Participants will take the supplement 30 -60 minutes before their meal and will then drink an additional glass of water. Participants will be instructed not to take the supplement less than 2 hours before bedtime. The test product may be consumed before breakfast, lunch, or dinner. First week: Start with 1 serving per day Rest of the study period: Increase to 2 servings per day at 2 different times during the day. |
The product contains the following ingredients: Psyllium Seed Husk Powder L-Carnitine Tartrate Capsimax® Cayenne Fruit Extract Chromium (as Chromium Picolinate) Vitamin B6 (as Pyridoxine HCl) Vitamin B12 (as Cyanocobalamin) Iron |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Body Weight. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Participants will provide body weight measurements using a weighing scales.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Waist Circumference. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Participants will independently measure their waist circumference in inches.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Hip Circumference. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Participants will independently measure their hip circumference in inches.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Thigh Circumference. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Participants will independently measure their thigh circumference in inches.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Overall Health. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-perceived changes in overall health.
On the scale, 1=worst response, and 5= the most favorable response.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Energy Levels. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-perceived changes in energy levels.
On the scale, 1=worst response, and 5= the most favorable response.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Tiredness. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-perceived changes in tiredness.
On the scale, 1=worst response, and 5= the most favorable response.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Overall Mood. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-perceived changes in overall mood.
On the scale, 1=worst response, and 5= the most favorable response.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Mental Wellbeing. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-perceived changes in mental wellbeing.
On the scale, 1=worst response, and 5= the most favorable response.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Ability to Focus. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-perceived changes in ability to focus.
On the scale, 1=worst response, and 5= the most favorable response.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Amount of Daily Leisure Time Spent Doing Something Active. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in the amount of daily leisure time spent active.
On the scale, 1=least amount of time, and 5= the most amount of time.
1= 0-15min; 2= 15-30min; 3= 30-60min; 4=60-90 min; 5=more than 90min
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Frequency of Constipation. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in frequency of constipation.
On the scale, 1=worst response, and 5= the most favorable response.
1= Never; 2= Less than once per week; 3= Once per week; 4= 2-5 times per week; 5= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Severity of Constipation. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in severity of constipation.
On the scale, 1=worst response, and 5= the most favorable response.
1= Not noticeable; 2= Barely noticeable; 3= Moderate; 4= Distracting ; 5= Severe.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Bowel Movement Regularity. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in bowel movement regularity.
On the scale, 1=worst response, and 5= the most favorable response.
1= Never; 2= Less than once per week; 3= Once per week; 4= 2-5 times per week; 5= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Frequency of Gas. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in frequency of gas.
On the scale, 1=worst response, and 5= the most favorable response.
5= Never; 4= Less than once per week; 3= Once per week; 2= 2-5 times per week; 1= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Severity of Gas. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in severity of gas.
On the scale, 1=worst response, and 5= the most favorable response.
5= Not noticeable; 4= Barely noticeable; 3= Moderate; 2= Distracting; 1= Severe.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Frequency of Bloating. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in frequency of bloating.
On the scale, 1=worst response, and 5= the most favorable response.
5= Never; 4= Less than once per week; 3= Once per week; 2= 2-5 times per week; 1= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Severity of Bloating. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in severity of bloating.
On the scale, 1=worst response, and 5= the most favorable response.
5= Not noticeable; 4= Barely noticeable; 3= Moderate; 2= Distracting; 1= Severe.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Discomfort Associated With Gut Issues. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, and Week 10
|
Survey-based assessment on a 7-point Likert scale of participant-reported changes in frequency of constipation.
On the scale, 1=worst response, and 7= the most favorable response.
7= No discomfort at all; 6= Minor discomfort; 5= Mild discomfort; 4= Moderate discomfort; 3= Moderately severe discomfort; 2= Severe discomfort; 1= Very severe discomfort.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, and Week 10
|
|
Changes in Frequency of Feeling Hunger After Eating a Meal. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-report changes in frequency of feeling hungry even after eating a meal.
On the scale, 1=worst response, and 5= the most favorable response.
5= Never; 4= Less than once per week; 3= Once per week; 2= 2-5 times per week; 1= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Number of Bowel Movements Per Week. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Participants were asked to report the number of bowel movements they had in the previous week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in the Frequency of Experiencing Food Cravings. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in frequency of constipation.
On the scale, 1=worst response, and 5= the most favorable response.
5= Never; 4= Less than once per week; 3= Once per week; 2= 2-5 times per week; 1= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
|
Changes in Frequency of Overeating. [Baseline to Week 12]
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Survey-based assessment on a 5-point Likert scale of participant-reported changes in frequency of constipation.
On the scale, 1=worst response, and 5= the most favorable response.
5= Never; 4= Less than once per week; 3= Once per week; 2= 2-5 times per week; 1= More than 5 times per week.
|
Baseline, Week 1, Week 2, Week 3, Week 4, Week 6, Week 8, Week 10, and Week 12
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Changes in Weight. [Baseline to Week 12]
Time Frame: 12 weeks
|
At baseline and endline, participants provided three photos from their chin down to their knees at the following angles: front-facing, side profile, and facing backward.
These photos were not analyzed or included in the data analysis.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20349
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruiting
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Colon Broom Premium supplement
-
Wageningen University and ResearchRadboud University Medical Center; Dutch Ministry of Defense; DSM; Thales; CircadianRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Donders Centre for Cognitive NeuroimagingWageningen University and ResearchCompletedAging | Cognitive DeclineNetherlands